REDBURN CANADA CONFERENCE NOVEMBER 17, 2021

Robert Adolph - VP Investor Relations Alicia Cahill - Sr Mgr Investor Relations

© Copyright

Safe harbor statement: This presentation includes certain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Act of 1934, as amended. Forward-looking statements are inherently subject to risks and uncertainties, many of which cannot be predicted with accuracy or might not even be anticipated. The Company has based these forward-looking statements on current estimates and assumptions which we believe are reasonable and which are made to the best of our knowledge. Actual results could differ materially from those included in the forward-looking statements due to various risk factors and uncertainties, including changes in business, economic or competitive conditions, changes in reimbursement, regulatory compliance issues, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, cyber security issues and the availability of financing. Given these uncertainties, readers should not put undue reliance on any forward-looking statements. These and other risks and uncertainties are discussed in detail in Fresenius Medical Care AG & Co. KGaA's (FMC AG & Co. KGaA) Annual Report on Form 20-F under the heading "Forward-Looking Statements" and under the headings in that report referred to therein, and in FMC AG & Co. KGaA's other reports filed with the Securities and Exchange Commission (SEC) and the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse).

Forward-looking statements represent estimates and assumptions only as of the date that they were made. The information contained in this presentation is subject to change without notice and the company does not undertake any duty to update the forward-looking statements, and the estimates and assumptions associated with them, except to the extent required by applicable law and regulations.

If not mentioned differently the term net income after minorities refers to the net income attributable to the shareholders of Fresenius Medical Care AG Co. KGaA. The term EMEA refers to the region Europe, Middle East and Africa. Amounts are in Euro if not mentioned otherwise.

© Copyright

1

2

AGENDA

3

4

5

AT A GLANCE

STRATEGY

MEDICAL UPDATE

BUSINESS UPDATE

FINANCIALS & OUTLOOK

9M 2021 | DELIVERING THE UPMOST QUALITY OF CARE

+2% Clinics

(1%) Patients

4,151

344,872

(1%) Treatments

Quality remains

on a consistently

39,510,028

high level

Clinics and patients as of September 30, 2021

Company Presentation November 2021

Page 4

FY 2020 | €17.9BN REVENUE

NORTH AMERICA

EMEA

Operating

Operating

Revenue

Patients

Clinics

Revenue

Patients

Clinics

Income

70%

Income

15%

€12.5bn

€2,120m

~210,300

~2,640

of total

€2.8bn

€412m

~66,000

~800

of total

revenue

revenue

+4%cc

+20%cc

0%

+2%

+5%cc

(6)%cc

0%

+3%

LATIN AMERICA

ASIA-PACIFIC

Operating

Operating

Revenue

Patients

Clinics

4%

11%

Revenue

Patients

Clinics

Income

Income

€0.7bn

€(157)m

~37,200

~250

of total

of total

revenue

€1.9bn

€344m

~33,100

~400

revenue

+21%cc

n.a.

+7%

+6%

+3%cc

+5%cc

0%

0%

cc = at constant currency

Segment revenue and operating income FY 2020, number of patients and clinics as of YE 2020, yoy change

Service

Product

revenue

revenue

Company Presentation November 2021

Page 5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

FMC - Fresenius Medical Care AG & Co. KGaA published this content on 17 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 December 2021 09:31:30 UTC.